Analyst desks were busy Wednesday. Several notable target price moves stand out across pharma, tech, and energy.
Eli Lilly got a consensus target price boost to $1,210. The pharma giant's GLP-1 drug pipeline continues to draw bullish calls. Lilly carries a near-$862 billion market cap and remains a Wall Street favourite.
The biggest move came from Evercore ISI's Amit Daryanani. He lifted his target on Seagate Technology from $750 to $1,000 — a 33% jump — while reiterating Buy. He also raised his target on data-centre play Vertiv Holdings from $350 to $425, again keeping a Buy rating. Both calls reflect growing confidence in AI infrastructure demand.
RTX Corporation picked up an upgrade. The defence giant moved from Hold to Buy. Analysts see the stock as a beneficiary of elevated global defence spending.
In energy, a sweep of recommendations were removed for ConocoPhillips, , , and . This signals a possible broker reassessment of the energy sector amid oil price swings.
JP Morgan cut its target on The Mosaic Company from $24 to $19, keeping a Sell rating. Fertiliser stocks remain under pressure from lower commodity prices.
CRH plc received a fresh new recommendation from the consensus. The building materials giant trades near $143 average analyst target with strong Buy-side support.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
